CLGNNasdaq Israel
Market cap
$6.406 M
$0.34 +2.45%
Close of 7 Aug 2026
Revenue
$2.37M
#3414 by revenue
Earnings
-$11.5M
Loss-making
Shares outstanding
12,803,006
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for CollPlant Biotechnologies are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.